All Stories

Jazz 'active and looking' at M&A deals of 'various sizes' as it wraps up Epidiolex patent fights: execs

Merely a minute into his prepared remarks during Jazz Pharmaceuticals’ fourth-quarter earnings call, CEO Bruce Cozadd brought investors’ attention to the company’s appetite in dealmaking.

Feb 26, 2025 - 17:13
 0
Jazz 'active and looking' at M&A deals of 'various sizes' as it wraps up Epidiolex patent fights: execs
Merely a minute into his prepared remarks during Jazz Pharmaceuticals’ fourth-quarter earnings call, CEO Bruce Cozadd brought investors’ attention to the company’s appetite in dealmaking.
Read More

Tags:

Previous Article

DHL sells 91-year-old Midwest LTL carrier

Next Article

AstraZeneca’s next breast cancer drug; Madrigal’s accelerating MASH launch

Related Posts

Don't call it a comeback: Pfizer returns to Super Bowl with ad pledging to 'knock out' cancer

Don't call it a comeback: Pfizer returns to Super Bowl ...

Feb 9, 2025  0

MaaT Pharma : Pioneering microbiome-driven therapy as new pillar in oncology

MaaT Pharma : Pioneering microbiome-driven therapy as n...

Feb 10, 2025  0

With recent launches and more to come, Amgen's biosimilar business is trending up

With recent launches and more to come, Amgen's biosimil...

Feb 9, 2025  0